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Volume 60, Number 4 Abstracts 1107Objectives: Mechanical assist devices have assumed an increasingly
important role in the management of high-risk cardiac patients. The Impella
LP 2.5, the ﬁrst percutaneous left ventricular assist device (LVAD), is placed
in the left ventricle under ﬂuoroscopic guidance via a 13F sheath. The low
cardiac output, large sheath size, and frequent presence of peripheral artery
disease in these patients increases the risk of vascular complications (VCs)
with this device. This study was undertaken to deﬁne the incidence of
VCs and assess their effect on patient outcome.
Methods: Between July 2010 and December 2013, an Impella
LVAD device was placed in 94 patients at our institution. Patient demo-
graphics, comorbidities, complications, and 30-day mortality were
reviewed.
Results: Mean age was 67 years (range, 17-97 years), 58% were
male, 69% had a history of hypertension, 39% were diabetic, 76% had
hyperlipidemia, 55% had a history of tobacco abuse, and 65% had renal
insufﬁciency (glomerular ﬁltration rate <60 mL/min/1.73 m2). The me-
dian preprocedure cardiac ejection fraction was 30%. The majority of
cases (80) were pericoronary artery intervention. The procedure was per-
formed emergently in 54 patients. The average duration of Impella sup-
port was 1 day (range, 1-5 days). Fifteen patients (17%) had at least one
VC. Of the 11 patients with acute limb ischemia, three improved after
LVAD removal, six required open or endoluminal repair with limb
salvage in ﬁve, and two required primary above-knee amputation. Other
VCs included groin hematoma in three patients and one pseudoaneur-
ysm. Patients with a VC had a longer length of stay (average 22 days
vs 10 days for those without a VC; P ¼ .014). Thirty-day mortality
was 44% (53% in those with VC and 43% in those without; P ¼ .43).
Care was withdrawn in 18 patients (19%) or they were sent to hospice.
There was an increased incidence of care withdrawal and hospice (40% vs
15%; P ¼ .021) in patients with a VC.
Conclusions: VCs are not uncommon with placement of percuta-
neous LVADs (17%). More importantly, their occurrence is associated
with increased length of stay and acceptance of end-of-life measures in
this high-risk population.
Author Disclosures: L. Kabbani: None; M. Abaunza: None; P. Balraj:
None; A. Greenbaum: None; A. Shepard: None.
Long-Term Results of Intentional Celiac Artery Coverage During
Endovascular Thoracic Aortic Aneurysm Repair
Melanie Rose, MD, Benjamin Pearce, MD, Marc Passman, MD, Thomas
Matthews, MD, Mark Patterson, MD, William Jordan, MD. Vascular and
Endovascular Therapy, UAB, Birmingham, Ala
Objectives: Coverage of the celiac artery (CA) during thoracic
endovascular aortic repair (TEVAR) to provide an adequate distal sealing
zone has been described, but only preliminary results have been reported.
We aim to show the long-term outcome for celiac coverage during
TEVAR.
Methods: Patients undergoing TEVAR with coverage of the CA
origin from 2005 to 2013 were identiﬁed and retrospectively analyzed.
End points included indications for covering the CA, demonstration of
collateral circulation between the CA and the superior mesenteric artery
(SMA), anatomic features of the distal landing zone, rate of delayed reinter-
vention, technical success, presence of long-term clinical ischemic symptoms
after the procedure, and mortality.
Results: During the 8-year period, 366 patients underwent TEVAR,
18 (5%) of which had CA coverage. Indications included thoracic aneu-
rysm (11 of 18), thoracic dissection (three of 18); and type Ib endoleak
after prior TEVAR requiring extension stent graft (four of 18). At the
conclusion of the indicated procedure, 11% (two of 18) had a type Ib
endoleak related to inadequate sealing at the SMA origin and 11% (two
of 18) had a type Ia endoleak. Three of these four type I endoleaks
required reintervention, one of which was an elective secondary conversion
to open repair 2 months later. One patient (5.5%) had immediate transient
abdominal pain with transaminase elevation that resolved without interven-
tion. A second patient developed ischemic symptoms when the endograft
migrated over the SMA origin, but this was successfully treated with an
SMA stent. Other postoperative complications included spinal cord
ischemia in two patients (11%), both of which resolved prior to discharge
with one requiring intervention in the form of spinal drainage, cerebrovas-
cular event in one (5.5%), and death in one (5.5%). No additional patient
developed weight loss, postprandial pain, or computed tomography evi-
dence of bowel ischemia during surveillance up to 78 months (mean, 37
months).
Conclusions: This long-term series supports the suitability in selected
patients of covering the CA for extending distal landing zone to the visceral
aorta above the SMA. Delayed visceral ischemic symptoms are uncommon,
and the collateral ﬂow to the CA appears to be stable over time.Author Disclosures: M. Rose: None; B. Pearce: None; M. Passman:
None; T. Matthews: None; M. Patterson: None; W. Jordan: None.
Operative Management of Hepatic Artery Aneurysms: Open and
Endovascular Techniques
Young Erben, Randall De Martino, Haraldur Bjarnason, MD, Manju
Kalra, MD, Gustavo Oderich, MD, Mark Fleming, MD, Thomas
Bower, MD, Peter Gloviczki, MD. Mayo Clinic, Rochester, Minn
Objectives: Degenerative hepatic artery aneurysms (HAAs) are an un-
common pathology. The aim of this study was to evaluate the approach and
outcomes in operative management of HAAs with open techniques (OTs)
and endovascular techniques (ETs).
Methods: Nineteen patients who underwent intervention for an HAA
from January 1992 to March 2014 were retrospectively reviewed. Primary
outcomes included morbidity and mortality of interventions for OTs and
ETs. Secondary outcomes included long-term survival, patency, and need
for reintervention.
Results: Fourteen (74%) patients were male, with a mean age of 65
years (range, 30-80 years), including six (32%) patients with connective tissue
disorders and one (5%) with syphilitic arteritis. Most patients (58%) had syn-
chronous aneurysms elsewhere. Mean HAA size was 42 6 22 mm (11 com-
mon hepatic, 5 common and proper hepatic, 1 accessory left hepatic, and 2
right hepatic). Right upper quadrant pain was the most common symptom
(37%), followed by transaminitis (5%) and obstructive jaundice (5%). Four
patients (21%) presented ruptured. The OT was bypass in 14 patients with
HAA involving the common hepatic (n ¼ 15) and the right hepatic (n ¼
1) arteries (seven with great saphenous vein graft, six with Dacron, one
with polytetraﬂuoroethylene), aneurysmorrhaphy alone, and patch repair in
one each. Postoperative complications occurred in ﬁve patients (26%)
including hemorrhage in two, graft thrombosis in two (re-explored in
one), and common bile duct stricture that required reoperation in one. ET
of coil embolization was performed electively in three patients (two limited
to the common and one to the right hepatic arteries) without sequelae. Over-
all mortality was 16% (5% undergoing elective surgical repair vs and 50% for
ruptured repair). Mean follow-up was 34 6 46 months. Overall survival was
84% at 5 years. Primary and secondary graft patency was 86% at 5 years. One
further graft occluded at 10 years and was not intervened upon.
Conclusions: Open repair remains the mainstay treatment for degen-
erative HAA repairs to preserve arterial ﬂow to the liver. However, coil
embolization may be applied safely in select patients with aneurysms not
involving the proper hepatic artery.
Author Disclosures: Y. Erben: None; R. De Martino: None; H.
Bjarnason: None; M. Kalra: None; G. Oderich: None; M. Fleming:
None; T. Bower: None; P. Gloviczki: None.
Clinical and Ultrasound Sequelae of Nonvisualized Calf Veins on
Duplex Ultrasonography for Suspected Deep Vein Thrombosis
Jon C. Henry, MD, David Strosberg, MD, Shantanu Warhadpande
Bhagwan Satiani, MD, Michael R. Go, MD. Surgery, The Ohio State
University Wexner Medical Center, Columbus, Ohio
Objectives: Calf veins are not visualized in up to 35% of lower ex-
tremity venous duplex ultrasound (DUS) scans. Little is known about the
clinical implications of nonvisualized calf veins. We sought to investigate
the incidence of nonvisualized calf veins, rate of subsequent venous throm-
boembolism (VTE), and factors inﬂuencing successful visualization on sub-
sequent DUS scans.
Methods: We reviewed all patients who had DUS scans in 2012 at
our institution with nonvisualized calf veins, no deep vein thrombosis
(DVT), and available follow-up. Demographics, Well’s score, body mass in-
dex, reason for the DUS scan, activity level, reason for nonvisualization,
initial and subsequent DUS results, and subsequent occurrence of VTE
were collected.
Results: A total of 8237 DUS scans were performed in 2012. Of
these, 891 DUS scans (10.8%) in 717 patients had nonvisualized calf
veins. The study population comprised 484 of these patients who had
no DVT and had available follow-up. The most common reasons for
nonvisualization were edema (35.5%) and body habitus (31.8%). Ten
pulmonary emboli (PE) and 13 DVT comprising 23 VTE (4.8%)
were subsequently identiﬁed in the population. No tested variables
correlated with development of VTE. Of the 484 patients, 148 had a
subsequent DUS scan at a median of 2.43 months, and 45.3% of the
subsequent DUS scans successfully imaged the previously nonvisualized
veins. Lower body weight, whole leg swelling, single vein nonvisualiza-
tion, and single limb nonvisualization at the initial DUS scan were asso-
ciated with successful visualization on subsequent DUS scans. Thirteen
(8.8%) new DVTs were seen on subsequent DUS scans; six were seen in
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femoral veins or calf veins that previously were visualized and did not
have clot (Table).
Conclusions: Nonvisualized calf veins are common in DUS imag-
ing. Almost half of patients with nonvisualized veins on the initial DUS
imaging had successful visualization on subsequent DUS scans. Lower
body weight, whole leg swelling, single vein nonvisualization, and sin-
gle limb nonvisualization on the initial DUS scan were associated with
successful visualization on subsequent DUS scans. Of patients with
nonvisualized veins on the initial DUS scan, 4.8% go on to develop
VTE, and 8.8% of patients who have subsequent DUS scans are found
to have DVT. When the initial DUS scan is unable to visualize calf
veins, a repeat DUS scan may be useful to identify new or initially un-
seen DVT.Table. Factors associated with development of subsequent venous
thromboembolism (VTE) or successful calf vein visualization on
subsequent duplex ultrasound (DUS) scans after nonvisualization of calf
veins on the initial DUS scan
Factor
Development of
subsequent VTE
Successful
visualization of
calf veins on
subsequent DUS
P value,
c2 or t-testa
P value,
c2 or t-testa
Demographics
Gender 1.000 .187
Age .440 .726
Height .884 .861
Weight .580 .0497
Body mass index .532 .056
Well’s score criteria
Active malignancy .210 .125
Recent surgery or trauma .105 .832
Whole leg swelling .984 .025
Calf swelling 1.000 .058
Pitting Edema .513 1.000
Prior DVT 1.000 .578
Collateral superﬁcial vein 1.000 .453
Paralysis, cast or, immobilization .783 .344
Pain along deep veins .435 1.00
Alternative diagnosis .533 .650
Well’s score .833 .071
Initial DUS
Single or multiple
nonvisualized veins
.826 < .001
One or both lower extremities 1.000 .021
Reason for nonvisualization
Bandage .626 .294
Body habitus .502 .157
Wound 1.000 .453
Edema .822 .063
Multiple .610 1.000
Reason for DUS
Concern for PE .103 .042
Lower extremity swelling .132 .045
Abnormal laboratory values 1.000 .453
Pain .718 .448
Other 1.000 .546
Multiple .264 .184
Postimaging anticoagulation .410 1.000
DVT, Deep vein thrombosis; PE, Pulmonary embolism.
aP < .05 is statistically signiﬁcant.Author Disclosures: J. C. Henry: None; D. Strosberg: None; S.
Warhadpande: None; B. Satiani: None; M. R. Go: None.
Postoperative Transfusion Is Associated With a Dramatic Increase in
30-Day Morbidity and Mortality in Patients Undergoing Major
Vascular Surgery
Andrea Obi,1 Yeo Jung-Park,1 Paul Bove,2 Robert Cuff,3 Andris Kazmers,4
Hitinder Gurm,1 Paul M. Grossman,1 Peter Henke1. 1University of
Michigan, Ann Arbor, Mich; 2Beaumont Hospitals, Royal Oak, Mich;
3SpectrumHospital, Grand Rapids, Mich; 4Mclearn Hospital, Petosky, MichObjectives: Blood transfusions are very common among patients un-
dergoing major vascular surgery. Prior studies suggest an association be-
tween blood transfusion and increased morbidity and mortality among
patients undergoing cardiac surgery. The effect of transfusion on patients
undergoing vascular surgery has been poorly deﬁned.
Methods: We examined data from a large multicenter quality
improvement vascular surgical registry of all patients undergoing elective
or urgent open peripheral arterial disease (PAD) procedures, endovascular
aneurysm repair (EVAR), or open abdominal aortic aneurysm (AAA)
repair between 2012 and 2013. Emergency cases, carotid endarterec-
tomy, and carotid artery stenting were excluded. Univariate and multivar-
iate logistic regression modeling was used to identify the effect of
transfusion on outcomes and predictors of transfusion. All regression
models had a Hosmer-Lemeshow P > .05 and area under receiver oper-
ating characteristic curve of >0.8, conﬁrming excellent goodness of ﬁt
and discrimination.
Results: Our study population comprised 2946 patients who un-
derwent open PAD procedures (n ¼ 1744), open AAA (n ¼ 175),
or EVAR (n ¼ 1027) at 22 hospitals. The overall transfusion rate
was 18%, at a median nadir hemoglobin of 7.7 g/dL. Adjusting for
major covariates, including preoperative anemia (hemoglobin <12 g/
dL), medications (including antiplatelets and anticoagulants), demo-
graphics, and comorbidities, transfusion was independently associated
with myocardial infarction (odds ratio [OR], 10.1; 95% conﬁdence in-
terval [CI], 5.2-19), death (OR, 3.8; 95% CI, 2.1-7), surgical site
infection (OR, 2.2; 95% CI, 1.3-3.5), and pneumonia (OR, 8.9; 95%
CI, 4.1-19). Independent factors predicting transfusion included female
gender (OR, 2.2; 95% CI, 1.7-2.7), body mass index (OR, 1.005; 95%
CI, 1.002-1.01), preoperative anemia (OR, 3.1; 95% CI, 2.4-3.8),
congestive heart failure (OR, 1.4; 95% CI, 1.1-1.9), clopidogrel (OR,
1.7; 95% CI, 1.3-2.2), open AAA repair (OR, 10.1; 95% CI, 6.5-
15.5), open bypass (OR, 3.1; 95% CI, 1.9-5.2), and urgent procedures
(OR, 1.4; 95% CI, 1.01-1.8).
Conclusions: Postoperative transfusion in vascular surgical patients is
independently associated with increased 30-day mortality and morbidity.
The risk of adverse cardiovascular events, including myocardial infarction,
was worsened rather than improved with transfusion. These data suggest
the need for a prospective comparative hemoglobin threshold study in
vascular surgical patients.
Author Disclosures: A. Obi: None; Y. Jung-Park: None; P. Bove: None;
R. Cuff: None; A. Kazmers: None; H. Gurm: None; P. M. Grossman:
None; P. Henke: None.
A Novel Atraumatic Method of Arterial Plaque Debulking
Zheng Wang,1 Zachary M. Emond, MD,2 Courtney E. Morgan, MD,1
Melina R. Kibbe, MD1. 1Feinberg School of Medicine, Northwestern
University, Chicago, Ill; 2University of Washington, Seattle, Wash
Objectives: Current percutaneous vascular interventions to treat se-
vere atherosclerosis induce mechanical or thermal injury to the vessel
wall, which stimulates the development of neointimal hyperplasia and re-
sults in restenosis. The objective of this study was to develop a paradigm-
shifting methodology to reduce plaque burden without inducing trauma
to the arterial wall. We hypothesized that a digestion solution tailored to
the components of atherosclerotic plaques would effectively digest pla-
ques in situ.
Methods: After IRB approval, carotid plaques from endarterec-
tomies were collected, sectioned (200-mg segments), and exposed to
our digestion solution (10 mg/mL collagenase types I, III, IV, V,
and 10mM CaCl2) with ultrasonic sonication (20 kHz) at 42C, pH
7.2, for 20 minutes. Specimens were weighed at baseline and every
10 minutes. Superﬁcial femoral and popliteal arteries were harvested
from limb amputations and cut into 3-cm sections. The lumen was
exposed to our digestion solution or phosphate-buffered saline
(PBS), with or without ultrasonic sonication, for 1 hour or 20 mi-
nutes. Arterial segments were mounted in parafﬁn, sectioned, and
stained with hematoxylin and eosin, van Gieson, and Masson tri-
chrome. Plaque and medial area from ﬁve sections spaced 0.2 mm
apart were analyzed for each artery.
Results: First, we evaluated our optimized digestion solution
with sonication on the harvested human plaques. We found that our
therapy reduced plaque mass by 75% 6 6% at 15 minutes and by
86% 6 3% at 30 minutes vs PBS with sonication (12% 6 4% at 20 mi-
nutes; P < .05). Next, we evaluated the efﬁcacy of our digestion so-
lution on intact arteries. Our digestion solution with sonication
resulted in 92% reduction of the plaque area compared with PBS
with sonication at 1 hour (31%; P < .05). Medial area was constant
across all groups. Notably, the internal elastic lamina was intact after
